atropine has been researched along with amiodarone in 36 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (amiodarone) | Trials (amiodarone) | Recent Studies (post-2010) (amiodarone) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 8,156 | 743 | 1,889 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.11) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 18 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Budriesi, R; Chiarini, A; Ioan, P; Micucci, M; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Broustet, JP; Griffo, R; Guern, P; Laylavoix, F; Seriès, E | 1 |
| Chamberlain, D; von Planta, M | 1 |
| Antiu'fev, VF; Arkhipov, MV | 1 |
| Pidrman, V; Pleskot, M; Tilser, P | 1 |
| Liberman, BA; Teasdale, SJ | 1 |
| Bellina, V; Dias Da Silva, VJ; Gnecchi-Ruscone, T; Lavelli, B; Malliani, A; Manzella, D; Montano, N; Porta, A | 1 |
| Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
| Borel, CO; Lin, JA; Wang, WB; Wong, CS; Wu, CT; Yang, CP; Yeh, CC | 1 |
| Chiribiri, A; Di Bella, G; Marte, F; Patanè, S | 1 |
| Trappe, HJ | 1 |
| Boyd, T; Brady, W | 1 |
| Hollinger, MK; Rosini, JM | 1 |
| Carron, PN; Pasquier, M; Santos, D; Yersin, B | 1 |
| Mumma, BE; Umarov, T | 1 |
| Andersen, LW; Berg, KM; Donnino, MW; Grossestreuer, AV; Moskowitz, A; Ross, CE | 1 |
3 review(s) available for atropine and amiodarone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The "Code Drugs in Cardiac Arrest"--the use of cardioactive medications in cardiac arrest resuscitation.
Topics: Advanced Cardiac Life Support; Amiodarone; Atropine; Cardiotonic Agents; Epinephrine; Heart Arrest; Humans; Lidocaine; Practice Guidelines as Topic; Resuscitation; Vasopressins | 2012 |
EZ-IO(®) intraosseous device implementation in a pre-hospital emergency service: A prospective study and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Analgesics; Anti-Arrhythmia Agents; Atropine; Bronchodilator Agents; Child; Child, Preschool; Critical Illness; Crystalloid Solutions; Emergency Medical Services; Epinephrine; Female; Humans; Hypoglycemia; Infusions, Intraosseous; Isotonic Solutions; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Prospective Studies; Respiratory Distress Syndrome; Shock; Status Epilepticus; Tibia; Wounds and Injuries; Young Adult | 2013 |
33 other study(ies) available for atropine and amiodarone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Electric Stimulation; Guinea Pigs; Heart; Heart Rate; Ileum; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Platelet Aggregation Inhibitors; Quinolizidines; Receptor, Muscarinic M2; Stereoisomerism; Structure-Activity Relationship; Vasodilator Agents | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Prinzmetal's angina initiated by interruption of exercise. 5 cases with normal coronary radiograms].
Topics: Adult; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Atropine; Coronary Angiography; Coronary Disease; Exercise Test; Humans; Male; Middle Aged; Nifedipine | 1979 |
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Calcium; Cardiopulmonary Resuscitation; Combined Modality Therapy; Electric Countershock; Humans; Lidocaine; Magnesium; Ventricular Fibrillation | 1992 |
[Anti-arrhythmic activity of atropine, ritmilen, obsidan and cordarone in patients with ventricular allorhythmia].
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atropine; Cardiac Complexes, Premature; Disopyramide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propranolol | 1989 |
[Combinations of anti-arrhythmia agents and the heart conduction system].
Topics: Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Drug Therapy, Combination; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Metaproterenol; Middle Aged | 1988 |
Anaesthesia and amiodarone.
Topics: Adult; Aged; Amiodarone; Anesthesia, General; Anesthetics; Atropine; Benzofurans; Bradycardia; Cardiac Output; Drug Interactions; Female; Heart Block; Humans; Male; Middle Aged; Retrospective Studies | 1985 |
Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atropine; Autonomic Fibers, Preganglionic; Baroreflex; Bradycardia; Cardiovascular System; Decerebrate State; Efferent Pathways; Hypotension; Injections, Intravenous; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Vagus Nerve | 2002 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Bradycardia; Calcium Gluconate; Cardiotonic Agents; Colorectal Surgery; Dopamine; Electric Countershock; Epinephrine; Fatal Outcome; Female; Heart Arrest; Heart Massage; Humans; Hypotension; Intraoperative Complications; Multiple Organ Failure; Pacemaker, Artificial; Tachycardia, Ventricular; Vasoconstrictor Agents | 2006 |
Conduction disturbances and paroxysmal atrial fibrillation during acute inferior myocardial infarction.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Atropine; Cortisone; Heart Conduction System; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Potassium | 2008 |
[Life-threatening brady- and tachyarrhythmias].
Topics: Adenosine; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Bradycardia; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Emergencies; Epinephrine; Heart Rate; Humans; Pacemaker, Artificial; Signal Processing, Computer-Assisted; Tachycardia | 2010 |
Advanced cardiac life support: what's new, what's old?
Topics: Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Atropine; Epinephrine; History, 20th Century; Humans; Muscarinic Antagonists; Practice Guidelines as Topic; Sympathomimetics | 2012 |
Sex differences in the prehospital management of out-of-hospital cardiac arrest.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Atropine; Cardiopulmonary Resuscitation; Databases, Factual; Emergency Medical Services; Epinephrine; Female; Humans; Lidocaine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Out-of-Hospital Cardiac Arrest; Practice Guidelines as Topic; Retrospective Studies; Sex Factors; Time-to-Treatment | 2016 |
Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atropine; Bicarbonates; Calcium; Epinephrine; Female; Glucose; Guideline Adherence; Heart Arrest; Hospitalization; Humans; Lidocaine; Logistic Models; Magnesium; Male; Middle Aged; Odds Ratio; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vasoconstrictor Agents; Vasopressins | 2019 |